Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) open the trading on February 11, 2021, with great promise as it jumped 1.05% to $7.68. During the day, the stock rose to $7.75 and sunk to $7.26 before settling in for the price of $7.60 at the close. Taking a more long-term approach, HJLI posted a 52-week range of $5.28-$20.25.
Meanwhile, its Annual Earning per share during the time was -39.80%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 72.30%. This publicly-traded company’s shares outstanding now amounts to $2.23 million, simultaneously with a float of $1.75 million. The organization now has a market capitalization sitting at $15.51 million. At the time of writing, stock’s 50-day Moving Average stood at $8.79, while the 200-day Moving Average is $9.32.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 12 workers. It has generated 2,604 per worker during the last fiscal year. Meanwhile, its income per employee was -635,450. The stock had 1.95 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks operating margin was -22681.85 and Pretax Margin of -24406.74.
Hancock Jaffe Laboratories Inc. (HJLI) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. Hancock Jaffe Laboratories Inc.’s current insider ownership accounts for 2.80%, in contrast to 0.50% institutional ownership. According to the most recent insider trade that took place on Aug 21, this organization’s Former 10% Owner sold 75,000 shares at the rate of 0.38, making the entire transaction reach 28,500 in total value, affecting insider ownership by 1,405,433. Preceding that transaction, on Aug 20, Company’s Former 10% Owner sold 75,000 for 0.27, making the whole transaction’s value amount to 20,250. This particular insider is now the holder of 1,480,433 in total.
Hancock Jaffe Laboratories Inc. (HJLI) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 9/29/2020 suggests? It has posted -$1.25 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$1.25) by $0. This company achieved a net margin of -24406.74 while generating a return on equity of -503.93. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.96 per share during the current fiscal year.
Hancock Jaffe Laboratories Inc.’s EPS increase for this current 12-month fiscal period is 72.30% and is forecasted to reach -3.78 in the upcoming year.
Hancock Jaffe Laboratories Inc. (NASDAQ: HJLI) Trading Performance Indicators
Let’s observe the current performance indicators for Hancock Jaffe Laboratories Inc. (HJLI). It’s Quick Ratio in the last reported quarter now stands at 3.10. The Stock has managed to achieve an average true range (ATR) of 0.81.
In the same vein, HJLI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -8.04, a figure that is expected to reach -0.99 in the next quarter, and analysts are predicting that it will be -3.78 at the market close of one year from today.
Technical Analysis of Hancock Jaffe Laboratories Inc. (HJLI)
[Hancock Jaffe Laboratories Inc., HJLI] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 21.12% While, its Average True Range was 0.87.
Raw Stochastic average of Hancock Jaffe Laboratories Inc. (HJLI) in the period of the previous 100 days is set at 7.83%, which indicates a major fall in contrast to 17.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 98.30% that was lower than 100.79% volatility it exhibited in the past 100-days period.